G. Stiens

发表

Aβ peptide1–42, Tau protein and S-100B protein level in cerebrospinal fluid of three patients with primary progressive aphasia

M. Otto, Johannes Meller, G. Stoppe, 2002, Neuroscience Letters.

Development of an international schedule for the assessment and staging of care for dementia.

A. Burns, Julie Morris, U. Volpe, 2015, Journal of Alzheimer's disease : JAD.

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

A. Sinclair, A. Hout, K. Blennow, 2019, Alzheimer's & Dementia.

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer’s disease

J. Wiltfang, B. Mollenhauer, H. Kretzschmar, 2005, Journal of Neural Transmission.

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2007, Molecular Psychiatry.

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

P. Lewczuk, J. Kornhuber, J. Wiltfang, 2007, Molecular psychiatry.

Abeta peptide 1-42, Tau protein and S-100B protein level in cerebrospinal fluid of three patients with primary progressive aphasia.

J. Wiltfang, M. Otto, Johannes Meller, 2002, Neuroscience letters.

Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome

W. Paulus, S. Happe, C. Trenkwalder, 2005, Journal of Neurology.

Clozapine-associated elevation of plasma cholinesterase

E. Rüther, J. Wiltfang, S. Bleich, 2001, European Archives of Psychiatry and Clinical Neuroscience.

Filial maturity as a predictor for the burden of demented parents’ caregivers

G. Stoppe, L. Maeck, G. Stiens, 2006, Zeitschrift für Gerontologie und Geriatrie.